Search Within

Mikhail Roshal

Formats
  1. Meeting Abstract (109)
  2. Journal Article (82)
  3. Book Section (15)
  4. Research Letter (11)
  5. Review (9)
  6. Correspondence (1)
  7. Editorial (1)
  8. Guidelines (1)
Groups
  1. Department of Pathology and Laboratory Medicine (229)
  2. Center for Hematologic Malignancies (151)
  3. Department of Medicine (143)
  4. Hematologic Malignancies, Division of (142)
  5. Adult Leukemia (98)
  6. Sloan Kettering Institute Postdocs (73)

More Groups

People
  1. Ahmet Dogan (95)
  2. Maria Arcila (68)
  3. Qi Gao (64)
  4. Wenbin Xiao (63)
  5. Yanming Zhang (58)
  6. Sergio Giralt (39)

More People

Years
  1. 2025 (8)
  2. 2024 (9)
  3. 2023 (26)
  4. 2022 (23)
  5. 2021 (27)
  6. 2020 (26)

More Years

Publications
  1. Blood (63)
  2. Laboratory Investigation (23)
  3. Modern Pathology (18)
  4. Blood Advances (15)
  5. Transfusion Medicine and Hemostasis: Clinical and Laboratory Aspects. 3rd ed (14)
  6. Cytometry Part B—Clinical Cytometry (7)

More Publications

Publishers
  1. American Society of Hematology (78)
  2. Nature Publishing Group (29)
  3. Elsevier Inc. (24)
  4. Nature Research (19)
  5. Wiley Blackwell (13)
  6. Elsevier Science, Inc. (8)

More Publishers

Results (229)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Annotation of somatic genomic variants in hematologic diseases using OncoKB, a precision oncology knowledgebase
    Meeting Abstract

    Suehnholz, S. P.; Kundra, R.; Roshal, M.; Xiao, W.; Petrova-Drus, K.; Yabe, M.; Ho, C.; Zhang, H.; Knorr, D.; Miles, L. A.; more...
    Blood (2019)

    Fulltext@MSK | Save
  • Bone marrow morphologic findings in patients receiving IDH inhibitor therapy in combination with intensive induction chemotherapy: Challenges with interpretation of the day 14 bone marrow biopsy
    Meeting Abstract

    Mason, E. F.; Pozdnyakova, O.; Roshal, M.; Fathi, A. T.; Stein, E. M.; Shaver, A. C.; Frattini, M. G.; Wang, H.; Hua, L.; Mu, J.; more...
    Blood (2019)

    Fulltext@MSK | Save
  • Long-term sustained minimal residual disease (MRD) negativity in multiple myeloma patients treated with lenalidomide maintenance therapy: A clinical and correlative phase 2 study
    Meeting Abstract

    Landgren, O.; Mastey, D.; Lesokhin, A. M.; Smith, E. L.; Shah, U. A.; Mailankody, S.; Hultcrantz, M.; Hassoun, H.; Lu, S. X.; Salcedo, M.; more...
    Blood (2019)

    Fulltext@MSK | Save
  • Acute leukemia with lineage infidelity: Mixed phenotype AML exhibits a distinct immunophenotype with clinical features overlapping mixed phenotype acute leukemia
    Meeting Abstract

    Kresch, M. P.; Xiao, W.; Menghrajani, K.; Famulare, C.; Patel, M. A.; Baik, J.; Roshal, M.; Levine, R. L.; Tallman, M. S.; Glass, J. L.
    Blood (2019)

    Fulltext@MSK | Save
  • Evaluation of tagraxofusp (SL-401) alone and in combination with ruxolitinib for the treatment of myeloproliferative neoplasms
    Meeting Abstract

    Krishnan, A.; Pagane, M.; Roshal, M.; McGovern, E.; Stone-Molloy, Z.; Chen, J.; Brooks, C.; Levine, R. L.; Rampal, R. K.
    Blood (2019)

    Fulltext@MSK | Save
  • Plasma cell myeloma residual disease quantitation using a next-generation sequencing-based IGH clonal rearrangement assay with the aid of a "spike-in" clonal sequence
    Meeting Abstract

    Ho, C.; Syed, M.; Yu, W.; Petrova-Drus, K.; Yao, J. J.; Moung, C.; Chang, J.; Benhamida, J.; Vanderbilt, C.; Roshal, M.; more...
    Blood (2019)

    Fulltext@MSK | Save
  • Comparison of MALDI-TOF mass spectrometry analysis of peripheral blood and bone marrow based flow cytometry for tracking measurable residual disease (MRD) in patients with multiple myeloma
    Meeting Abstract

    Eveillard, M.; Rustad, E. H.; Roshal, M.; Zhang, Y.; Ciardiello, A. K.; Korde, N.; Hultcrantz, M.; Hassoun, H.; Smith, E. L.; Lesokhin, A. M.; more...
    Blood (2019)

    Fulltext@MSK | Save
  • CD4 lymphocytes and T regulatory cells show distinct phenotypes in follicular lymphoma and classical Hodgkin lymphoma which may account for differences in responses to checkpoint therapy
    Meeting Abstract

    El Daker, S.; Gao, Q.; Roshal, M.; Dogan, A.
    Blood (2019)

    Fulltext@MSK | Save
  • Plasmacytoid dendritic cell proportion is predictive of risk and outcomes in myelodysplastic syndromes
    Meeting Abstract

    Chan, A.; Zhang, Y.; Devlin, S. M.; Lewis, N.; Baik, J.; Arcila, M. E.; Klimek, V. M.; Roshal, M.; Xiao, W.
    Blood (2019)

    Fulltext@MSK | Save
  • Antithrombin testing
    Book Section

    Roshal, M.; Reyes Gil, M.
    In Shaz, B. H.; Hillyer, C. D.; Reyes Gil, M. (Eds.) Transfusion Medicine and Hemostasis: Clinical and Laboratory Aspects. 3rd ed (2019)

    Fulltext@MSK | Save